Mediclinic recognised as SA’s most valuable healthcare brand for five consecutive years
Posted on 5 June 2018
For the fifth year in succession, Mediclinic has been recognised as the most valuable healthcare brand in the ‘Most Valuable Brands’ list for 2018.
“Mediclinic moved up in the top brands ranking to 14, compared to number 16 in 2017, which testifies to our brand delivering on its promise of ‘Expertise you can trust’”, says Dr Biren Valodia, Mediclinic Southern Africa’s Chief Marketing Officer. “The increase in Mediclinic’s brand value demonstrates how patients are recognising the quality of care being delivered in our hospitals. Our position as the top healthcare brand among iconic South African brands such as MTN, FNB and Sasol demonstrates the value of our focus on building a brand through expert care,” he concludes.
Brand Finance uses a unique methodology to calculate a brand’s value, which involves estimating the likely future sales that are attributable to a brand and calculating a royalty rate that would be charged for the use of the brand. Essentially, what a potential owner would have to pay for the use of the brand if it were not already owned. The brands are then listed by financial valuation in South Africa and their part in driving competitiveness and the nation’s reputation.
Jeremy Sampson, Executive Director of Brand Finance Africa comments, “Last year we noted the value of the South African 50 top brands was R395bn, showing a growth of 3% on 2016, so outpacing the growth of the country’s economy.” This year the value has grown dramatically by 8% to R426bn as the economy shows signs of recovery from the previous decade. “The potential for South Africa going forward is huge, especially as new brands emerge,” Sampson concludes.
Mediclinic Southern Africa is part of the Mediclinic International Group, an international private healthcare group founded in 1983, with operations in Southern Africa (South African and Namibia), Switzerland and the United Arab Emirates. The Company’s primary listing is on the LSE in the United Kingdom, with secondary listings on the JSE in South Africa and the NSX in Namibia. The Group’s registered office is in London, United Kingdom.